Clinical Trials Directory

Trials / Suspended

SuspendedNCT04222803

VIRal Hepatitis and GAllstone Disease Study

Viral Hepatitis and Gallstone Disease Study

Status
Suspended
Phase
Study type
Observational
Enrollment
350 (estimated)
Sponsor
Göteborg University · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The study aims to investigate possible associations between ongoing viral hepatitis (i.e. hepatitis A, B, C or E virus infection) and ultrasound or computed tomography-verified gallstone disease.

Detailed description

Patients seeking care at emergency room at Sahlgrenska University Hospital, Gothenburg, Sweden undergoing ultrasound or computed tomography for suspected gallstone disease, will be asked if they wish to participate in the study. If they agree, a serum sample will be draw for analysis of anti-HAV IgM, HBsAg, anti-HCV, HCV Core antigen and HEV RNA. The proportion of patients with vs. without ultrasound or computed tomography-verified gallstone disease will be evaluated regarding possible ongoing viral hepatitis (i.e. hepatitis A, B, C or E virus infection).

Conditions

Timeline

Start date
2022-10-07
Primary completion
2027-10-09
Completion
2027-12-31
First posted
2020-01-10
Last updated
2025-04-09

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT04222803. Inclusion in this directory is not an endorsement.

VIRal Hepatitis and GAllstone Disease Study (NCT04222803) · Clinical Trials Directory